Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccine Response in Pregnancy
NCT03888989Phase 1Terminated
- Sponsor
- Stanford University
- Start
- Sep 2019
- Primary completion
- Dec 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of influenza virus quadrivalent inactivated vaccine in influenza, sponsored by Stanford University. Primary endpoints: Plasma Hemagglutination Inhibition Titer and Number of Participants With Related Adverse Events. Started Sep 2019; status: terminated.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03888989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03888989.